• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行对法布雷病患者的影响:意大利经验。

Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experience.

机构信息

Institute for Biomedical Research and Innovation, National Research Council of Italy, Palermo, Italy.

Respiratory Diseases Unit, Department of Medical Sciences, University Hospital of Siena (Azienda Ospedaliera Universitaria Senese, AOUS), Siena, Italy.

出版信息

Mol Genet Metab. 2020 Sep-Oct;131(1-2):124-125. doi: 10.1016/j.ymgme.2020.07.008. Epub 2020 Jul 28.

DOI:10.1016/j.ymgme.2020.07.008
PMID:32741663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7386205/
Abstract

We conducted an observational study to assess the impact of COVID-19 emergency on management and outcomes of patients with Fabry disease referring to our Center in Naples, Italy. No patient of the 129 included reported suspected symptoms; 3 isolated themselves in auto-quarantine for flu-like symptoms. All treated patients regularly continued their therapies; 8 missed one infusion: 3 for self-isolation with 2 relatives, and 3 refused to receive nurse at home. All elective procedures were deferred and telemedicine was adopted.

摘要

我们进行了一项观察性研究,以评估 COVID-19 紧急情况对意大利那不勒斯我院就诊的法布病患者的治疗和结局的影响。129 例患者中无一人报告疑似症状;3 人因流感样症状自我隔离。所有接受治疗的患者均定期继续接受治疗;8 人漏注一次:3 人因与 2 名亲属自我隔离,3 人拒绝护士上门。所有择期手术均推迟并采用远程医疗。

相似文献

1
Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experience.COVID-19 大流行对法布雷病患者的影响:意大利经验。
Mol Genet Metab. 2020 Sep-Oct;131(1-2):124-125. doi: 10.1016/j.ymgme.2020.07.008. Epub 2020 Jul 28.
2
Fabry disease during the COVID-19 pandemic. Why and how treatment should be continued.COVID-19 大流行期间的法布瑞病。为什么以及如何应继续治疗。
Mol Genet Metab. 2020 Aug;130(4):227-229. doi: 10.1016/j.ymgme.2020.06.002. Epub 2020 Jun 6.
3
Embracing Change: Learnings From Implementing Multidimensional Digital Remote Monitoring in Oncology Patients at a District General Hospital During the COVID-19 Pandemic.拥抱变革:新冠疫情期间在一家地区综合医院对肿瘤患者实施多维数字远程监测的经验教训
JCO Clin Cancer Inform. 2021 Feb;5:216-220. doi: 10.1200/CCI.20.00136.
4
A rational approach to COVID-19.对 COVID-19 的理性应对。
Hum Genomics. 2020 Dec 22;14(1):47. doi: 10.1186/s40246-020-00300-5.
5
Fertility care amidst the COVID19 pandemic: the American experience.新冠疫情期间的生育保健:美国经验。
J Ovarian Res. 2021 Feb 18;14(1):34. doi: 10.1186/s13048-021-00782-4.
6
Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?从 COVID-19 疫情中吸取的意大利临床研究运营经验:我们学到了什么,未来可以应用哪些经验?
Tumori. 2021 Feb;107(1):6-11. doi: 10.1177/0300891620977916. Epub 2020 Dec 9.
7
Impact of COVID-19 Outbreak through Telemedicine Implementation on Data Reporting During Oncology Clinical Trials.COVID-19 疫情期间通过实施远程医疗对肿瘤临床试验数据报告的影响。
Cancer Invest. 2021 Jan;39(1):15-20. doi: 10.1080/07357907.2020.1858311. Epub 2020 Dec 10.
8
Challenges of Cancer Immunotherapy during the COVID-19 Pandemic.新冠疫情期间癌症免疫疗法面临的挑战
Cancer Invest. 2021 Feb;39(2):115-119. doi: 10.1080/07357907.2020.1864129. Epub 2020 Dec 27.
9
Satisfaction among Cancer Patients Undergoing Radiotherapy during the COVID-19 Pandemic: An Institutional Experience.2019年冠状病毒病大流行期间接受放疗的癌症患者的满意度:一项机构经验
Curr Oncol. 2021 Apr 10;28(2):1507-1517. doi: 10.3390/curroncol28020142.
10
Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge.Covid-19 紧急情况下核医学设施对分化型甲状腺癌的管理:远程医疗的挑战。
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):831-836. doi: 10.1007/s00259-020-05041-0. Epub 2020 Sep 23.

引用本文的文献

1
COVID-19 and Vaccination Status in Lysosomal Storage Diseases: A Single-Center Experience.溶酶体贮积症中的新冠病毒感染及疫苗接种状况:单中心经验
Turk Arch Pediatr. 2023 May;58(3):262-267. doi: 10.5152/TurkArchPediatr.2023.22233.
2
The impact of the COVID-19 pandemic on Fabry Disease Patients: an examination of Mood Status, Therapy Adherence, and COVID-19 infection.COVID-19 大流行对法布雷病患者的影响:情绪状态、治疗依从性和 COVID-19 感染的考察。
Orphanet J Rare Dis. 2022 Sep 5;17(1):338. doi: 10.1186/s13023-022-02491-7.
3
COVID-19 in Fabry disease: a reference center prospective study.法布里病合并 COVID-19:参考中心前瞻性研究。
Orphanet J Rare Dis. 2022 Jun 28;17(1):250. doi: 10.1186/s13023-022-02386-7.
4
Severe manifestations and treatment of COVID-19 in a transplanted patient with Fabry disease.法布里病移植患者的新型冠状病毒肺炎严重表现及治疗
Mol Genet Metab Rep. 2021 Dec;29:100802. doi: 10.1016/j.ymgmr.2021.100802. Epub 2021 Sep 16.
5
Considerations for Home-Based Treatment of Fabry Disease in Poland during the COVID-19 Pandemic and Beyond.COVID-19 大流行期间及之后波兰居家治疗 Fabry 病的考虑因素。
Int J Environ Res Public Health. 2021 Aug 4;18(16):8242. doi: 10.3390/ijerph18168242.
6
Impact of the COVID-19 pandemic on the standard of care for patients with lysosomal storage diseases: A survey of healthcare professionals in the Fabry, Gaucher, and Hunter Outcome Survey registries.2019冠状病毒病大流行对溶酶体贮积症患者护理标准的影响:法布里病、戈谢病和亨特病结果调查登记处医疗保健专业人员的一项调查
Mol Genet Metab Rep. 2021 Sep;28:100788. doi: 10.1016/j.ymgmr.2021.100788. Epub 2021 Aug 4.
7
The Impact of the First 2020 COVID-19 Lockdown on the Metabolic Control of Patients with Phenylketonuria.2020 年新冠肺炎疫情封控对苯丙酮尿症患者代谢控制的影响。
Nutrients. 2021 Jun 12;13(6):2024. doi: 10.3390/nu13062024.
8
The Impact of the COVID-19 Pandemic on the Perception of Health and Treatment-Related Issues among Patients with Phenylketonuria in Poland-The Results of a National Online Survey.COVID-19 大流行对波兰苯丙酮尿症患者健康和治疗相关问题认知的影响——全国在线调查结果。
Int J Environ Res Public Health. 2021 Jun 13;18(12):6399. doi: 10.3390/ijerph18126399.
9
Gaucher disease in the COVID-19 pandemic environment: The good, the bad and the unknown.新冠疫情环境下的戈谢病:有利之处、不利之处与未知因素
Mol Genet Metab. 2021 Apr;132(4):213-214. doi: 10.1016/j.ymgme.2021.02.005. Epub 2021 Feb 24.
10
Fabry disease and COVID-19: international expert recommendations for management based on real-world experience.法布里病与新型冠状病毒肺炎:基于真实世界经验的国际管理专家建议
Clin Kidney J. 2020 Dec 24;13(6):913-925. doi: 10.1093/ckj/sfaa227. eCollection 2020 Dec.

本文引用的文献

1
Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience.新型冠状病毒肺炎相关医疗危机对溶酶体贮积症患者治疗的影响:意大利的首例经验
Mol Genet Metab. 2020 Jul;130(3):170-171. doi: 10.1016/j.ymgme.2020.04.002. Epub 2020 Apr 29.
2
The epidemiology and clinical information about COVID-19.新型冠状病毒肺炎的流行病学和临床信息。
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1011-1019. doi: 10.1007/s10096-020-03874-z. Epub 2020 Apr 14.
3
Current and Investigational Therapeutics for Fabry Disease.法布里病的现有及研究性治疗方法
Kidney Int Rep. 2019 Dec 6;5(4):407-413. doi: 10.1016/j.ekir.2019.11.013. eCollection 2020 Apr.
4
Supporting the Health Care Workforce During the COVID-19 Global Epidemic.在新冠疫情全球大流行期间为医护人员提供支持。
JAMA. 2020 Apr 21;323(15):1439-1440. doi: 10.1001/jama.2020.3972.
5
Fabry disease.法布里病
Handb Clin Neurol. 2015;132:231-48. doi: 10.1016/B978-0-444-62702-5.00017-2.